For Sale, Buyer Sought: Teva Confirms API Unit Is On The Block

‘Pretty Neutral With Regards To Margins,’ Teva Says; H1 2025 Deadline Forecast

 
• By Dean Rudge
  
For sale sign_56496355_1200.jpg
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business